| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$276 |
Change in substantial holding
|
30 May 2025 10:02AM |
$0.365 |
$0.265 |
fallen by
27.40%
|
|
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$80 |
Dr John Byon appointed Chief Medical Officer
|
30 May 2025 9:57AM |
$0.016 |
$0.250 |
risen by
1,462.50%
|
|
| Pureprofile Ltd (PPL) ORDINARY FULLY PAID |
Information Technology |
$50 |
Change in substantial holding
|
30 May 2025 9:52AM |
$0.041 |
$0.043 |
risen by
4.88%
|
|
| Dorsavi Ltd (DVL) ORDINARY FULLY PAID |
Health Care |
$34 |
dorsaVi Signs 3-year Deal with Mining Health Leader
|
30 May 2025 9:52AM |
$0.013 |
$0.030 |
risen by
130.77%
|
|
DVL - Price-sensitive ASX Announcement
Full Release
Key Points
- dorsaVi Ltd has signed a 3-year deal with mining health leader DVL.
- The agreement will see dorsaVi provide its wearable sensor technology and analytics platform.
- The technology will be used to monitor and improve worker musculoskeletal health and safety.
- This partnership represents a major commercial milestone for dorsaVi.
- The deal is expected to generate significant recurring revenue for dorsaVi.
- The contract reinforces dorsaVi’s position in the workplace health and safety market.
- There is growing demand for workplace health technology in the mining and resource sectors.
- The agreement highlights dorsaVi’s expertise in sensor-based safety solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Patrys Limited (PAB) ORDINARY FULLY PAID |
Health Care |
$19 |
Trading Halt
|
30 May 2025 9:50AM |
$0.002 |
$0.035 |
risen by
2,233.33%
|
|
PAB - Price-sensitive ASX Announcement
Full Release
Key Points
- Patrys Limited requests a trading halt from the ASX.
- The trading halt is effective from 6 June 2024.
- The trading halt is pending an announcement regarding a proposed capital raising.
- The halt will remain until the earlier of the announcement release or the start of trading on 10 June 2024.
- The company aims to keep the market fully informed.
- Patrys Limited confirms no other information relevant to the trading halt is outstanding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WT Financial Group Limited (WTL) ORDINARY FULLY PAID |
Financials |
$46 |
Change of Director's Interest Notice
|
30 May 2025 9:43AM |
$0.125 |
$0.135 |
risen by
8%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,703 |
Change of Director's Interest Notice - RL
|
30 May 2025 9:43AM |
$2.780 |
$4.270 |
risen by
53.60%
|
|
| Intelligent Investor Australian Equity Growth Fund (Managed Fund) (IIGF) |
Financials |
$89 |
Change of investment strategy
|
30 May 2025 9:42AM |
$2.900 |
$3.010 |
risen by
3.79%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,703 |
Change of Director's Interest Notice - ML
|
30 May 2025 9:41AM |
$2.780 |
$4.270 |
risen by
53.60%
|
|
| Beamtree Holdings Limited (BMT) ORDINARY FULLY PAID |
Health Care |
$44 |
Strategic Partnership with NHS Confederation
|
30 May 2025 9:41AM |
$0.275 |
$0.150 |
fallen by
45.45%
|
|
BMT - Price-sensitive ASX Announcement
Full Release
Key Points
- Beamtree Holdings Limited (BMT) has announced a strategic partnership with the NHS Confederation in the United Kingdom.
- The partnership aims to promote Beamtree’s data and decision support technologies, including its world-leading RippleDown and other AI-driven solutions, to NHS Confederation members.
- The NHS Confederation represents the vast majority of the organisations that comprise the NHS in England, Wales, and Northern Ireland, providing a significant opportunity for Beamtree’s market expansion.
- Beamtree will collaborate with the NHS Confederation to deliver thought leadership, foster engagement, and support digital transformation in healthcare.
- The partnership is designed to help drive better data quality, efficiency, and patient care outcomes across NHS member organisations.
- Beamtree’s CEO, Tim Kelsey, highlighted the importance of this partnership for scaling innovation and supporting NHS organisations through digital transformation.
- This collaboration is expected to increase Beamtree’s brand recognition and market presence within the UK healthcare sector.
- The partnership is non-exclusive and forms part of Beamtree’s global strategy to partner with leading healthcare institutions and networks.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Veris Limited (VRS) ORDINARY FULLY PAID |
Industrials |
$36 |
Update - Notification of buy-back - VRS
|
30 May 2025 9:40AM |
$0.047 |
$0.067 |
risen by
42.55%
|
|
| Barrow Hanley Global Share Fund (Managed Fund) (GLOB) |
Financials |
$462 |
Quarterly Portfolio Disclosure - March 2025
|
30 May 2025 9:40AM |
$5.060 |
$4.950 |
fallen by
2.17%
|
|
| Perpetual Ethical SRI Fund (Managed Fund) (GIVE) |
Financials |
$14 |
Quarterly Portfolio Disclosure - March 2025
|
30 May 2025 9:38AM |
$3.300 |
$2.920 |
fallen by
11.52%
|
|
| Manuka Resources Ltd (MKR) ORDINARY FULLY PAID |
Materials |
$169 |
Taranaki VTM Continues to Progress Through Fast-track
|
30 May 2025 9:37AM |
$0.036 |
$0.115 |
risen by
219.44%
|
|
MKR - Price-sensitive ASX Announcement
Full Release
Key Points
- Taranaki VTM Project continues to progress under a fast-track process.
- Project aims to produce vanadium, titanium, and magnetite products.
- Ongoing permitting and regulatory engagement with New Zealand authorities.
- Technical studies and feasibility assessment in progress.
- Environmental management and community engagement strategies implemented.
- Commitment to responsible resource development and environmental stewardship.
- Project seen as important for local economic growth and strategic minerals supply.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$9 |
Letter to Shareholders
|
30 May 2025 9:33AM |
$0.072 |
$0.029 |
fallen by
59.72%
|
|
| Havilah Resources Limited (HAV) ORDINARY FULLY PAID |
Materials |
$234 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
30 May 2025 9:33AM |
$0.185 |
$0.660 |
risen by
256.76%
|
|
HAV - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarter covers activities ended 31 March 2022.
- Operational updates provided for copper, gold, and iron ore projects in South Australia.
- Progress on drilling, resource definition, and project evaluation at the Kalkaroo, Mutooroo, and Grants projects.
- Kalkaroo Project Prefeasibility Study update and engagement with potential partners.
- Exploration drilling results received and analyzed for several tenements.
- Cash at bank and term deposits at quarter end was $5.6 million.
- Expenditure focused on advancing priority copper and gold projects.
- No production or sales revenues reported for the quarter.
- Appendix 5B provides detailed cash flow statement and financing activities.
- Prudent cost management emphasized to preserve cash reserves.
- Ongoing assessment of funding options and strategic opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Life360 Inc (360) CDI 3:1 FOREIGN EXEMPT XNGS |
Information Technology |
$4,350 |
AGM Results of Meeting
|
30 May 2025 9:32AM |
$33.370 |
$23.840 |
fallen by
28.56%
|
|
| Verity Resources Limited (VRL) ORDINARY FULLY PAID |
Materials |
$10 |
Monument Gold Project Drilling and Resource Upgrade Update
|
30 May 2025 9:31AM |
$0.028 |
$0.024 |
fallen by
14.29%
|
|
VRL - Price-sensitive ASX Announcement
Full Release
Key Points
- VRL completed an extensive RC drilling campaign at the Monument Gold Project.
- Drilling targeted infill and step-out areas to test and extend known gold mineralization zones.
- Numerous significant gold intercepts were reported, confirming the project's resource potential.
- Results support a forthcoming update to the mineral resource estimate.
- Drilling demonstrated both continuity and expansion potential for gold mineralization.
- Work included testing along strike and at depth, broadening the project's prospectivity.
- The company plans further metallurgical testwork to support resource development.
- VRL is planning additional exploration and development activities at Monument.
- The update is part of a broader strategy to grow and upgrade the project's resource base.
- The announcement underlines VRL's commitment to advancing the Monument Gold Project systematically and efficiently.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fat Prophets Global Contrarian Fund Limited (FPC) ORDINARY FULLY PAID |
Financials |
$45 |
Weekly NTA
|
30 May 2025 9:30AM |
$1.025 |
$1.595 |
risen by
55.61%
|
|
| Little Green Pharma Ltd (LGP) ORDINARY FULLY PAID |
Health Care |
$35 |
Appendix 4E and 2025 Annual Report
|
30 May 2025 9:30AM |
$0.105 |
$0.115 |
risen by
9.52%
|
|
LGP - Price-sensitive ASX Announcement
Full Release
Key Points
- LGP reported its financial results for the year ended 31 March 2024 in accordance with ASX Listing Rules and Australian Accounting Standards.
- The company experienced revenue growth compared to the prior year, attributed to increased sales in key markets and expanded product offerings.
- Detailed commentary is provided on operational achievements, including new market entries, product launches, and partnership developments.
- The report discusses significant changes in the company’s structure, including acquisitions, divestments, and changes in controlled entities.
- No final dividend has been declared or paid for the reporting period.
- Full audited financial statements are included, highlighting profitability, cash flow, and balance sheet position.
- Risks and uncertainties related to market conditions, regulatory changes, and supply chain are discussed as part of the directors’ report.
- The company outlines its future strategy focusing on growth, cost management, and capital allocation.
- Remuneration details for directors and key management personnel are disclosed in line with governance standards.
- The document is compliant with ASX and Australian reporting requirements and includes the auditor’s report and independence declaration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Capital Group Limited (PCG) ORDINARY FULLY PAID |
Financials |
$78 |
Update - Notification of buy-back - PCG
|
30 May 2025 9:28AM |
$0.790 |
$0.790 |
fallen by
0%
|
|
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$101 |
Update - Notification of buy-back - CAM
|
30 May 2025 9:27AM |
$0.730 |
$0.705 |
fallen by
3.42%
|
|
| IPH Limited (IPH) ORDINARY FULLY PAID |
Industrials |
$965 |
Update - Notification of buy-back - IPH
|
30 May 2025 9:25AM |
$4.940 |
$3.690 |
fallen by
25.30%
|
|
| Viva Energy Group Limited (VEA) ORDINARY FULLY PAID |
Energy |
$2,877 |
LNG Terminal Project Update
|
30 May 2025 9:25AM |
$1.880 |
$1.770 |
fallen by
5.85%
|
|
| Aguia Resources Limited (AGR) ORDINARY FULLY PAID |
Materials |
$28 |
Share Purchase Plan Offer Booklet
|
30 May 2025 9:25AM |
$0.039 |
$0.015 |
fallen by
62.82%
|
|
AGR - Price-sensitive ASX Announcement
Full Release
Key Points
- Aguia Resources Limited is conducting a Share Purchase Plan (SPP) to raise capital.
- The SPP allows eligible shareholders to purchase new AGR shares without brokerage fees.
- Funds raised will be used for project development, exploration, and working capital.
- Details of eligibility, application process, and key dates are outlined in the booklet.
- Risks of investment and company background information are included.
- Shareholders are encouraged to read the booklet and consider seeking professional advice before participating.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.